Form 4: 4D Molecular Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
David Kirn, See Remarks and a Director of 4D Molecular Therapeutics, Inc., sold 12,415 shares of common stock on August 3, 2026 for $10.05 per share.
Summary
- Open-market sale: disposed of 12,415 Common Stock at $10.05 ($124,722) on August 3, 2026; holds 871,737 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $124,722 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
David Kirn — Director, Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Open-market sale | Common Stock | 12,415 | $10 | $124.7K | 871,737 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Open-market sale (12,415 shares) |
Keywords
insider transaction, Form 4, FDMT, 4D Molecular Therapeutics, Inc., bearish, David Kirn
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.